Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care

Recruiting N/A Interventional Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 99
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
240 (estimated)
Sponsor
National Cancer Centre, Singapore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients: 1. 21 years or older and 2. able to communicate in English/Chinese/Malay and 3. be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and 4. have functional limitation of New…
Contacts

Dr Shirlyn Neo, MBBS, MRCP (UK), MMed, FAMS

+65 63065838

shirlyn.neo.h.s@singhealth.com.sg

CONTACT